SULAT JAMES R reported 1 transaction at ARCH THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/23/2020ACC: 0001104659-20-075860
+1.25M
Net shares
Net buyer
$37.19B
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.25M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+454.55K
Price / share
$81.82K
Trade value
$37.19B
% of position
49.3%
6/22/2020
922.27K→1.38M
Total
Net shares
+454.55K
Net value
$37.19B
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/22/2020 | O · O | +454.55K | $81.82K | $37.19B | 49.3% | 922.27K | 1.38M |
| Total | +454.55K | $37.19B | ||||||
Derivative Transactions2
Series D Warrant (right to buy)
Indirect
Converts to
Common Stock
454.55K shares
Shares
+454.55K
Strike price
0.18
Held after
0.00
Exercisable
—
6/22/2020
Series J Warrant (right to buy)
Indirect
Converts to
Common Stock
340.91K shares
Shares
+340.91K
Strike price
0.25
Held after
340.91K
Exercisable
—
6/22/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series D Warrant (right to buy) Indirect | Common Stock454.55K shares | 6/22/2020 | O · O | +454.55K | 0.18 | — | 0.00 |
| Series J Warrant (right to buy) Indirect | Common Stock340.91K shares | 6/22/2020 | P · Purchase | +340.91K | 0.25 | — | 340.91K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned370K
Total
370K direct370K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 370K | Direct |
| Total | 370K | 370K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported